Trademark Overview
On Friday, January 24, 2025, a trademark application was filed for TAIWAN BIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TAIWAN BIO THERAPEUTICS trademark a serial number of 99017731. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, January 24, 2025. This trademark is owned by TAIWAN BIO THERAPEUTICS INC.. The TAIWAN BIO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Syringes sold filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes sold filled with pharmaceuticals for chronic wound healing, including non-healing ulcers; Syringes sold filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes sold filled with pharmaceuticals for cardiovascular diseases, including acute myocardial infarction and ischemic conditions; Syringes sold filled with regenerative pharmaceuticals for skin and tissue repair; Biological tissue cultures for medical purposes; Medicinal syrups for the treatment of organ transplant rejection; Medicinal syrups for the treatment of transplant-related complications; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Biological preparations for use in cell cultures for medical purposes; Organotherapy preparations; Stem cells for medical purposes
Apparatus for the regeneration of stem cells for medical purposes
Providing reagent sample testing and diagnostic services for others for scientific research purposes; Providing medical and scientific research information in the field of clinical trials; Medical research laboratory services; Medical research services; Scientific research in the field of genetics; Research and development of new products for others; Technical writing; Scientific and technological services, namely, scientific research in the field of stem cell therapy and regenerative medicine, including treatments for degenerative diseases; Scientific and technological services, namely, scientific research in the field of cell-based pharmaceuticals and gene-editing technologies for chronic and acute diseases; Scientific and technological services, namely, scientific research in the field of anti-rejection therapies and regulatory T-cell technologies for organ transplantation; Technological research in the field of cell-based pharmaceutical development and manufacturing technologies; T...
